Unilateral vs. Bilateral Approaches to Hybrid Stroke Rehabilitation

July 6, 2016 updated by: Chang Gung Memorial Hospital
The aim of the project is to compare the effects of unilateral hybrid therapy [unilateral robot-assisted therapy (RT)] + unilateral arm training (UAT)] and bilateral hybrid therapy [bilateral RT + bilateral arm training (BAT)] on motor function, daily function, mobility, life quality, and motor control strategy in stroke patients.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kwei-Shan, Tao-Yuan, Taiwan, 333
        • Not yet recruiting
        • Chang Gung memorial hospital
      • New Taipei City, Taiwan
        • Recruiting
        • Taipei Hospital, Ministry of Health and Welfare
    • Toayuan county
      • Kwei-shan, Toayuan county, Taiwan, 333
        • Not yet recruiting
        • Lo-Sheng Sanatorium and Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. ≥3 months onset from a first-ever unilateral stroke;
  2. minimal motor criteria to receive CIT (i.e., ≥10º wrist extension and ≥ 10º extension at the thumb and any two other digits);
  3. an initial FMA-UE score of 10 to 56, indicating mild to moderate and moderate to severe upper extremity motor impairment;
  4. no excessive spasticity in any of the joints of the affected arm (shoulder, elbow, wrist, and fingers);
  5. able to follow instructions and perform the study tasks (Mini Mental State Examination ≥ 22);
  6. without upper extremity fracture within 3 months;
  7. no participation in any rehabilitation experiments or drug studies during the study period; and (8) willing to provide written informed consent.

Exclusion Criteria:

  1. acute inflammatory disease;
  2. major health problems or poor physical condition that might limit participation; and (3) attend any other study in recent 3 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Unilateral Hybrid Intervention Group
Participants will receive 6 weeks of bilateral RT training using the BMT and UAT training in each session.
For the unilateral RT training, participants will practice with their affected arms following a unilateral training protocol of BMT for 45 minutes (Yang, et al., 2012). For the UAT training, participants will receive training of the affected UL in functional tasks with behavioral shaping for 45 minutes (Lin, Wu, et al., 2009).
Experimental: Bilateral Hybrid Intervention Group
Participants will receive 6 weeks of bilateral RT training using the BMT and BAT training in each session.
For the bilateral RT training, patients will focus on training involving both arms using the BMT robot for 45 minutes. During the 45 minutes BAT training, participants will receive training in tasks focusing on bilateral symmetric or alternating movements of both ULs.
Experimental: Robot-Assisted Training Group
Participants will receive 6 weeks of RT training using the BMT in each session.
The RT intervention will be matched in duration and intensity with the hybrid interventions. Participants in the RT group will practice on the BMT with bilateral protocols for 90 minutes. The tasks will be tailored according to the level

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change scores of Fugl-Meyer assessment(FMA)
Time Frame: baseline, 3 weeks, 6 weeks, 18 weeks
baseline, 3 weeks, 6 weeks, 18 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Wolf Motor Function Test (WMFT)
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Box and block test (BBT)
Time Frame: baseline, 3 weeks, 6 weeks, 18 weeks
baseline, 3 weeks, 6 weeks, 18 weeks
Change scores of Action research arm test (ARAT)
Time Frame: baseline, 3 weeks, 6 weeks
baseline, 3 weeks, 6 weeks
Change scores of Medical Research Council scale (MRC)
Time Frame: baseline, 3 weeks, 6 weeks
baseline, 3 weeks, 6 weeks
Change scores of Modified Ashworth scale (MAS)
Time Frame: baseline, 3 weeks, 6 weeks
baseline, 3 weeks, 6 weeks
Change scores of Myoton
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Chedoke Arm and Hand Activity Inventory (CAHAI)
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Functional independent measure (FIM)
Time Frame: baseline, 3 weeks, 6 weeks
baseline, 3 weeks, 6 weeks
Change scores of Stroke Impact Scale (SIS 3.0 version)
Time Frame: baseline, 3 weeks, 6 weeks, 18 weeks
baseline, 3 weeks, 6 weeks, 18 weeks
Change scores of EuroQol Quality of Life Scale (EQ-5D)
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Hand strength
Time Frame: baseline, 3 weeks, 6 weeks
baseline, 3 weeks, 6 weeks
Change scores of Motor activity log (MAL)
Time Frame: baseline, 6 weeks, 18 weeks
baseline, 6 weeks, 18 weeks
Change scores of ABILHAND Questionnaire
Time Frame: baseline, 6 weeks, 18 weeks
baseline, 6 weeks, 18 weeks
Change scores of 10-meter walking test
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Nottingham Extended ADL Questionnaire (NEADL)
Time Frame: baseline, 6 weeks, 18 weeks
baseline, 6 weeks, 18 weeks
Change scores of Adelaide Activities Profile (AAP)
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Accelerometer
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of kinematic analysis
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Adverse effects
Time Frame: baseline, 3 weeks, 6 weeks
baseline, 3 weeks, 6 weeks
Change scores of Algometer
Time Frame: baseline, 6 weeks
baseline, 6 weeks
Change scores of Revised Nottingham Sensory Assessment (rNSA)
Time Frame: baseline, 6 weeks
baseline, 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2015

Primary Completion (Anticipated)

May 1, 2019

Study Completion (Anticipated)

May 1, 2019

Study Registration Dates

First Submitted

May 19, 2015

First Submitted That Met QC Criteria

May 20, 2015

First Posted (Estimate)

May 21, 2015

Study Record Updates

Last Update Posted (Estimate)

July 7, 2016

Last Update Submitted That Met QC Criteria

July 6, 2016

Last Verified

June 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Unilateral Hybrid Intervention

3
Subscribe